Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) EBIT Margin (2020 - 2022)

Sonoma Pharmaceuticals (SNOA) has 3 years of EBIT Margin data on record, last reported at 8.61% in Q4 2012.

  • For Q4 2012, EBIT Margin rose 9298.0% year-over-year to 8.61%; the TTM value through Dec 2012 reached 49.29%, up 211614.0%, while the annual FY2012 figure was 50.75%, 75798.0% up from the prior year.
  • EBIT Margin reached 8.61% in Q4 2012 per SNOA's latest filing, up from 17.16% in the prior quarter.
  • Across five years, EBIT Margin topped out at 22.67% in Q1 2011 and bottomed at 1094.06% in Q2 2010.
  • Average EBIT Margin over 3 years is 202.06%, with a median of 23.13% recorded in 2012.
  • The widest YoY moves for EBIT Margin: up 86442bps in 2012, down -4579bps in 2012.
  • A 3-year view of EBIT Margin shows it stood at 89.84% in 2010, then grew by 6bps to 84.37% in 2011, then surged by 110bps to 8.61% in 2012.
  • Per Business Quant database, its latest 3 readings for EBIT Margin were 8.61% in Q4 2012, 17.16% in Q3 2012, and 12.97% in Q2 2012.